Business Description
WAVE Life Sciences Ltd
ISIN : SG9999014716
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.33 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -8.31 | |||||
Debt-to-EBITDA | -0.39 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.51 | |||||
Beneish M-Score | 0.33 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.8 | |||||
3-Year EBITDA Growth Rate | 46.7 | |||||
3-Year EPS without NRI Growth Rate | 45.7 | |||||
3-Year FCF Growth Rate | 59.8 | |||||
3-Year Book Growth Rate | -41.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | -13.73 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.58 | |||||
9-Day RSI | 63.97 | |||||
14-Day RSI | 64.88 | |||||
6-1 Month Momentum % | -14.07 | |||||
12-1 Month Momentum % | -15.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.89 | |||||
Days Sales Outstanding | 32.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.7 | |||||
Shareholder Yield % | -8.53 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -75.74 | |||||
Net Margin % | -66.5 | |||||
FCF Margin % | -116.96 | |||||
ROA % | -31.98 | |||||
ROIC % | -46.97 | |||||
ROC (Joel Greenblatt) % | -233.72 | |||||
ROCE % | -109.18 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.24 | |||||
EV-to-EBIT | -13.04 | |||||
EV-to-EBITDA | -14.58 | |||||
EV-to-Revenue | 9.88 | |||||
EV-to-Forward-Revenue | 10.43 | |||||
EV-to-FCF | -8.42 | |||||
Earnings Yield (Greenblatt) % | -7.67 | |||||
FCF Yield % | -10.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
WAVE Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 102.587 | ||
EPS (TTM) (€) | -0.525 | ||
Beta | -0.99 | ||
Volatility % | 73.71 | ||
14-Day RSI | 64.88 | ||
14-Day ATR (€) | 0.311171 | ||
20-Day SMA (€) | 6.3645 | ||
12-1 Month Momentum % | -15.64 | ||
52-Week Range (€) | 3.28 - 8.1 | ||
Shares Outstanding (Mil) | 152.09 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
WAVE Life Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
WAVE Life Sciences Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
WAVE Life Sciences Ltd Frequently Asked Questions
What is WAVE Life Sciences Ltd(STU:1U5)'s stock price today?
When is next earnings date of WAVE Life Sciences Ltd(STU:1U5)?
Does WAVE Life Sciences Ltd(STU:1U5) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |